ArticlePediatric surgery international2026
Trends and outcomes of thoracoscopic esophageal atresia and tracheoesophageal fistula repair: a retrospective analysis 2016-2022.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Surgical Strategies for Native Esophagus Preservation in Long-Gap Esophageal Atresia: A 20-Year Population-Based Study.Journal of clinical medicine · 2026Article
- Comment on "Trends and outcomes of thoracoscopic esophageal atresia and tracheoesophageal fistula repair: a retrospective analysis 2016-2022".Pediatric surgery international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThoracoscopic repair of esophageal atresia (EA) and tracheoesophageal fistula (TEF) is a technically demanding operation. We hypothesize thoracoscopic repair of EA with TEF over time has increased, with improved or equivalent outcomes compared to open.
methodsNSQIP-P identified patients < 30 days with EA and TEF who underwent repair of both defects from 2016 to 2022. Patients were categorized into (1) intention to treat (thoracoscopic/thoracoscopic converted to open); and (2) thoracoscopic only, both compared to open only patients. Coarsened exact matching was performed. Pre/post-match analysis utilized X2, Fisher’s exact, and Mann-Whitney-U tests.
resultsOverall, 1,188 patients were identified with 147 (12.4%) thoracoscopic only, 129 (10.8%) converted to open, and 912 (76.8%) open only. Thoracoscopic repair increased (2016–2022) for intention to treat (12.0% vs. 29.4%, p = 0.001) and thoracoscopic only (7.2% vs. 19.1%, p = 0.012) cohorts. Matched analysis identified thoracoscopic patients had reduced length of stay (p = 0.005) and longer operative time (< 0.01); however, no difference in other outcomes were identified (p > 0.05).
conclusionThoracoscopic repair of EA with TEF attempts have increased to roughly 30%, and it is associated with reduced length of stay and longer operative times without other outcome differences. This analysis affirms the short-term safety of thoracoscopic repair of EA and TEF. LEVEL OF EVIDENCE (I-V): Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.